Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019

SELL
$12.61 - $22.33 $162,025 - $286,918
-12,849 Closed
0 $0
Q4 2018

Feb 05, 2019

SELL
$12.41 - $22.98 $32,774 - $60,690
-2,641 Reduced 17.05%
12,849 $175,000
Q3 2018

Nov 07, 2018

SELL
$2.45 - $16.27 $41,358 - $274,653
-16,881 Reduced 52.15%
15,490 $252,000
Q1 2018

May 08, 2018

BUY
$2.99 - $4.44 $12,312 - $18,283
4,118 Added 14.58%
32,371 $97,000
Q3 2017

Nov 07, 2017

BUY
$3.03 - $3.72 $3,287 - $4,036
1,085 Added 3.99%
28,253 $99,000
Q2 2017

Nov 20, 2017

BUY
N/A
27,168
27,168 $110,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $246M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.